You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas: Vaccines
GC Biopharma secures first Latin American approval for BARYCELA Inj.
Login
Username:

Password:


Related Headlines

EpiVax introduces AI-enhanced models for immunogenicity prediction

Pfizer and BioNTech granted FDA approval for XFG-adapted COVID-19 vaccine

4basebio announces strategic collaboration with Genezen

Charles River and Medigen collaborate on next-generation enterovirus vaccine development

Amplitude Therapeutics and Lilly collaborate on trans-amplifying RNA vaccine development for infectious diseases

Piramal Pharma acquires controlling stake in Yapan Bio

Innorna Nominated for 2026 Prix Galien USA Best Startup Award

Sanofi's MenQuadfi receives EU approval for infants from six weeks

Evaxion to present three-year cancer vaccine data at ESMO Congress 2026

Evaxion presents new preclinical data on cytomegalovirus vaccine EVX-V1

Northwest Biotherapeutics presents on propensity score matching at BNOS 2026

Taiwan biomedical startups hold over 100 business meetings at BIO 2026

SK bioscience to lead Gates Foundation-funded ROTOR project

Anixa Biosciences' breast cancer vaccine technology granted first Korean patent

Transgene expands myvac platform into non-small cell lung cancer with TG4070

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026